Serial #79279432
LIVE

Serial Number

79279432

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Dec 13, 2019

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79279432 Trademark

Serial Number: 79279432 • Registration: 6138796

Serial #79279432 is a trademark filed by NOVARTIS AG on December 13, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

December 13, 2019

Registration Date

September 1, 2020

Published for Opposition

June 16, 2020

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

INTERNATIONAL REGISTRATION RENEWED
Oct 9, 2025 RNWL
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 1, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 23, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 31, 2020 FICS
FINAL DISPOSITION PROCESSED
Dec 31, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 1, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 1, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 16, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 16, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 27, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 12, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 8, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 8, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 8, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 6, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 6, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 6, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 6, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 6, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 6, 2020 COAR
REFUSAL PROCESSED BY IB
Apr 24, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 28, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 28, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 10, 2020 RFCR
NON-FINAL ACTION WRITTEN
Mar 9, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 5, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 3, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 24, 2020 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Feb 20, 2020 SDRC